Biofunctional materials for directing vascular development

Current Vascular Pharmacology

Volumn 10, Issue 3, 2012, Pages 331-341

  Saik, Jennifer E ^a   McHale, Melissa K ^a   West, Jennifer L ^a  

^a Rice University   (United States)

Author keywords

Angiogenesis; Biomaterials; Blood vessels; Endothelial cells; Growth factors; Tissue engineering

Indexed keywords

ALGINIC ACID; BIOMATERIAL; CHITOSAN; FIBRIN; GROWTH FACTOR; POLY(ETHYLENE GLYCOL)DIACRYLATE; POLYGLACTIN; POLYURETHAN; UNCLASSIFIED DRUG;

ANGIOGENESIS; CELL ENCAPSULATION; CORNEA NEOVASCULARIZATION; HUMAN; MICROVASCULATURE; NONHUMAN; PROTEIN FUNCTION; REVIEW; TISSUE ENGINEERING;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROVESSELS; NEOVASCULARIZATION, PHYSIOLOGIC; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84860307742     PISSN: 15701611     EISSN: 18756212     Source Type: Journal    
DOI: 10.2174/157016112799959314     Document Type: Review

References (110)

1. UNOS. United Network for Organ Sharing. 2011 January 20, 2009.
2. Moon JJ, West JL. Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr Top Med Chem 2008; 8: 300-10.
3. Jain RK, Au P, Tam J, Duda DG, Fukumura D. Engineering vascularized tissue. Nat Biotechnol 2005; 23: 821-3.
4. Falanga V, Sabolinski M. A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999; 7: 201-7.
5. Atala A, Bauer SB, Soker S, Yoo JJ, Retik AB. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006; 367: 1241-6.
6. Allen KD, Athanasiou KA. Tissue engineering of the TMJ disc: a review. Tissue Eng 2006; 12: 1183-96.
7. Sun H, Liu W, Zhou G, Zhang W, Cui L, Cao Y. Tissue engineering of cartilage, tendon and bone. Front Med 2011; 5: 61-9.
8. Koike N, Fukumura D, Gralla O, Au P, Schechner JS, Jain RK. Tissue engineering: creation of long-lasting blood vessels. Nature 2004; 428: 138-9.
9. Langer R, Vacanti JP. Tissue engineering. Science 1993; 260: 920-6.
10. Seifalian AM, Tiwari A, Hamilton G, Salacinski HJ. Improving the clinical patency of prosthetic vascular and coronary bypass grafts: the role of seeding and tissue engineering. Artif Organs 2002; 26: 307-20.
11. Edelman DA, Jiang Y, Tyburski J, Wilson RF, Steffes C. Pericytes and their role in microvasculature homeostasis. J Surg Res 2006; 135: 305-11.
12. Betsholtz C, Lindblom P, Gerhardt H. Role of pericytes in vascular morphogenesis. EXS 2005: 115-25.
13. Madeddu P. Therapeutic angiogenesis and vasculogenesis for tissue regeneration. Exp Physiol 2005; 90: 315-26.
14. Nomi M, Miyake H, Sugita Y, Fujisawa M, Soker S. Role of growth factors and endothelial cells in therapeutic angiogenesis and tissue engineering. Curr Stem Cell Res Ther 2006; 1: 333-43.
15. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrixbound VEGF. Mol Biol Cell 1993; 4: 1317-26.
16. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380: 435-9.
17. Marti HH. Angiogenesis--a self-adapting principle in hypoxia. EXS 2005; (94): 163-80.
18. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45.
19. Jackson CL, Reidy MA. Basic fibroblast growth factor: its role in the control of smooth muscle cell migration. Am J Pathol 1993; 143: 1024-31.
20. Bar RS, Boes M, Booth BA, Dake BL, Henley S, Hart MN. The effects of platelet-derived growth factor in cultured microvessel endothelial cells. Endocrinology 1989; 124: 1841-8.
21. Lindahl P, Johansson BR, Leveen P, Betsholtz C. Pericyte loss and microaneurysm formation in PDGF-B-deficient mice. Science 1997; 277: 242-5.
22. Frontini MJ, Nong Z, Gros R, et al. Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cells. Nat Biotechnol 2011; 29: 421-7.
23. Vargas A, Zeisser-Labouebe M, Lange N, Gurny R, Delie F. The chick embryo and its chorioallantoic membrane (CAM) for the in vivo evaluation of drug delivery systems. Adv Drug Deliv Rev 2007; 59: 1162-76.
24. Laschke MW, Harder Y, Amon M, et al. Angiogenesis in tissue engineering: breathing life into constructed tissue substitutes. Tissue Eng 2006; 12: 2093-104.
25. Rogers MS, Birsner AE, D'Amato RJ. The mouse cornea micropocket angiogenesis assay. Nat Protoc 2007; 2: 2545-50.
26. Jain RK, Schlenger K, Hockel M, Yuan F. Quantitative angiogenesis assays: progress and problems. Nat Med 1997; 3: 1203-8.
27. Cao R, Brakenhielm E, Pawliuk R, et al. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 2003; 9: 604-13.
28. Leslie-Barbick JE, Saik JE, Gould DJ, Dickinson ME, West JL. The promotion of microvasculature formation in poly(ethylene glycol) diacrylate hydrogels by an immobilized VEGF-mimetic peptide. Biomaterials 2011; 32: 5782-9.
29. Poche RA, Saik JE, West JL, Dickinson ME. The mouse cornea as a transplantation site for live imaging of engineered tissue constructs. Cold Spring Harb Protoc 2010; 2010: pdb prot5416.
30. Mahadevan V, Hart IR, Lewis GP. Factors influencing blood supply in wound granuloma quantitated by a new in vivo technique. Cancer Res 1989; 49: 415-9.
31. Gazit Y, Baish JW, Safabakhsh N, Leunig M, Baxter LT, Jain RK. Fractal characteristics of tumor vascular architecture during tumor growth and regression. Microcirculation 1997; 4: 395-402.
32. Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res 2001; 7: 533-7.
33. Mandelbrot BB. The Fractal Geometry of Nature. 20th ed. New York: Freeman; 1982.
34. Sandau K, Kurz H. Measuring fractal dimension and complexity-an alternative approach with an application. J Microsc 1997; 186: 164-76.
35. Plotnick RE, Gardner RH, Hargrove WW, Prestegaard K, Perlmutter M. Lacunarity analysis: a general technique for the analysis of spatial patterns. Physical Review E 1996; 53: 5461.
36. Landini G, Murray PI, Misson GP. Local connected fractal dimensions and lacunarity analyses of 60 degrees fluorescein angiograms. Invest Ophthalmol Vis Sci 1995; 36: 2749-55.
37. Tolle CR, McJunkin TR, Gorsich DJ. An efficient implementation of the gliding box lacunarity algorithm. Physica D: Non-linear Phenomena 2008; 237: 306.
38. Avakian A, Kalina RE, Helene Sage E, et al. Fractal analysis of region-based vascular change in the normal and non-proliferative diabetic retina. Curr Eye Res 2002; 24: 274-80.
39. Masters B, Family F, Platt DE. Fractal analysis of human retinal vessels. Biophys J 1989; 55(575a).
40. Jain RK, Au P, Tam J, Duda DG, Fukumura D. Engineering vascularized tissue. Nat Biotechnol 2005; 23: 821.
41. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003; 9: 685.
42. Bassingthwaighte JB, Liebovitch LS, West BJ. Fractal physiology. New York, NY: Oxford University 1994.
43. Herman P, Kocsis L, Eke A. Fractal branching pattern in the pial vasculature in the cat. J Cereb Blood Flow Metab 2001; 21: 741.
44. Gould D, Vadakkan TJ. Poche RA, Dickinson ME. Multifractal analysis of vessel morphology and remodelling. Microcirculation 2011; 18: 136-51.
45. Doubal FN, MacGillivray TJ, Patton N, Dhillon B, Dennis MS, Wardlaw JM. Fractal analysis of retinal vessels suggests that a distinct vasculopathy causes lacunar stroke. Neurology 2010; 74: 1102-7.
46. Grauslund J, Green A, Kawasaki R, Hodgson L, Sjølie AK, Wong TY. Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes. Ophthalmology 2010; 117: 1400-5.
47. Sng CC, Sabanayagam C, Lamoureux EL, et al. Fractal analysis of the retinal vasculature and chronic kidney disease. Nephrol Dial Transplant 2010; 25: 2252-8.
48. Baish JW, Gazit Y, Berk DA, Nozue M, Baxter LT, Jain RK. Role of tumor vascular architecture in nutrient and drug delivery: an invasion percolation-based network model. Microvasc Res 1996; 51: 327-46.
49. Bui A, Šutalo I, Manasseh R, Liffman K. Dynamics of pulsatile flow in fractal models of vascular branching networks. Med Biol Eng Comput 2009; 47: 763-72.
50. Liu D, Wood NB, Witt N, Hughes AD, Thom SA, Xu XY. Computational analysis of oxygen transport in the retinal arterial network. Curr Eye Res 2009; 34: 945-56.
51. Bianchi F, Rosi M, Vozzi G, Emanueli C, Madeddu P, Ahluwalia A. Microfabrication of fractal polymeric structures for capillary morphogenesis: applications in therapeutic angiogenesis and in the engineering of vascularized tissue. J Biomed Mater Res B Appl Biomater 2007; 81: 462-8.
52. Guidolin D, Vacca A, Nussdorfer GG, Ribatti D. A new image analysis method based on topological and fractal parameters to evaluate the angiostatic activity of docetaxel by using the Matrigel assay in vitro. Microvasc Res 2004; 67: 117-24.
53. Drury JL, Mooney DJ. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003; 24: 4337-51.
54. Patel ZS, Mikos AG. Angiogenesis with biomaterial-based drug-and cell-delivery systems. J Biomater Sci Polym Ed 2004; 15: 701-26.
55. DeLong SA, Moon JJ, West JL. Covalently immobilized gradients of bFGF on hydrogel scaffolds for directed cell migration. Biomaterials 2005; 26: 3227-34.
56. Hahn MS, McHale MK, Wang E, Schmedlen RH, West JL. Physiologic pulsatile flow bioreactor conditioning of poly(ethylene glycol)-based tissue engineered vascular grafts. Ann Biomed Eng 2007; 35: 190-200.
57. Gunn JW, Turner SD, Mann BK. Adhesive and mechanical properties of hydrogels influence neurite extension. J Biomed Mater Res A 2005; 72: 91-7.
58. West JL, Hubbell JA. Polymeric biomaterials with degradation sites for proteases involved in cell migration. Macromolecules 1999 1999; 32: 241-4.
59. Hern D, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res 1997; 39: 266-76.
60. Mittermayr R, Morton T, Hofmann M, Helgerson S, van Griensven M, Redl H. Sustained (rh)VEGF(165) release from a sprayed fibrin biomatrix induces angiogenesis, up-regulation of endogenous VEGF-R2, and reduces ischemic flap necrosis. Wound Repair Regen 2008; 16: 542-50.
61. Poche RA, Larina IV, Scott ML, Saik JE, West JL, Dickinson ME. The Flk1-myr::mCherry mouse as a useful reporter to characterize multiple aspects of ocular blood vessel development and disease. Dev Dyn 2009; 238: 2318-26.
62. Moon JJ, Saik JE, Poche RA, et al. Biomimetic hydrogels with proangiogenic properties. Biomaterials 2010; 31: 3840-7.
63. Chinen N, Tanihara M, Nakagawa M, et al. Action of microparticles of heparin and alginate crosslinked gel when used as injectable artificial matrices to stabilize basic fibroblast growth factor and induce angiogenesis by controlling its release. J Biomed Mater Res A 2003; 67: 61-8.
64. Miyoshi M, Kawazoe T, Igawa HH, Tabata Y, Ikada Y, Suzuki S. Effects of bFGF incorporated into a gelatin sheet on wound healing. J Biomater Sci Polym Ed 2005; 16: 893-907.
65. Fujita M, Ishihara M, Shimizu M, et al. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Wound Repair Regen 2007; 15: 58-65.
66. Jin Q, Wei G, Lin Z, et al. Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS One 2008; 3: e1729.
67. Wong C, Inman E, Spaethe R, Helgerson S. Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 2003; 89: 573-82.
68. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH. Increased angiogenesis in acellular scaffolds by combined release of FGF2 and VEGF. J Control Release 2006; 116: e88-90.
69. Lee KY, Peters MC, Mooney DJ. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. J Control Release 2003; 87: 49-56.
70. Kano MR, Morishita Y, Iwata C, et al. VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 2005; 118(Pt 16): 3759-68.
71. Greenberg JI, Shields DJ, Barillas SG, et al. A role for VEGF as a negative regulator of pericyte function and vessel maturation. Nature 2008; 456: 809-13.
72. Cao Y, Cao R, Hedlund EM. Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J Mol Med 2008; 86: 785-9.
73. Baumgartner I, Rauh G, Pieczek A, et al. Lower-extremity edema associated with gene transfer of naked DNA encoding vascular endothelial growth factor. Ann Intern Med 2000; 132: 880-4.
74. Epstein SE, Kornowski R, Fuchs S, Dvorak HF. Angiogenesis therapy: amidst the hype, the neglected potential for serious side effects. Circulation 2001; 104: 115-9.
75. Semenza GL. Therapeutic angiogenesis: another passing phase? Circ Res 2006; 98: 1115-6.
76. Lee KY, Peters MC, Anderson KW, Mooney DJ. Controlled growth factor release from synthetic extracellular matrices. Nature 2000 Dec; 408: 998-1000.
77. Ennett AB, Kaigler D, Mooney DJ. Temporally regulated delivery of VEGF in vitro and in vivo. J Biomed Mater Res A 2006; 79: 176-84.
78. Richardson TP, Peters MC, Ennett AB, Mooney DJ. Polymeric system for dual growth factor delivery. Nat Biotechnol 2001; 19: 1029-34.
79. Chen RR, Silva EA, Yuen WW, Mooney DJ. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 2007; 24: 258-64.
80. Ehrbar M, Zeisberger SM, Raeber GP, Hubbell JA, Schnell C, Zisch AH. The role of actively released fibrin-conjugated VEGF for VEGF receptor 2 gene activation and the enhancement of angiogenesis. Biomaterials 2008; 29: 1720-9.
81. Steffens GC, Yao C, Prevel P, et al. Modulation of angiogenic potential of collagen matrices by covalent incorporation of heparin and loading with vascular endothelial growth factor. Tissue Eng 2004; 10: 1502-9.
82. Pieper JS, Hafmans T, van Wachem PB, et al. Loading of collagenheparan sulfate matrices with bFGF promotes angiogenesis and tissue generation in rats. J Biomed Mater Res 2002; 62: 185-94.
83. Maynard HD, Hubbell JA. Discovery of a sulfated tetrapeptide that binds to vascular endothelial growth factor. Acta Biomater 2005; 1: 451-9.
84. Koch S, Yao C, Grieb G, Prevel P, Noah EM, Steffens GC. Enhancing angiogenesis in collagen matrices by covalent incorporation of VEGF. J Mater Sci Mater Med 2006; 17: 735-41.
85. Moon JJ, Lee SH, West JL. Synthetic biomimetic hydrogels incorporated with ephrin-A1 for therapeutic angiogenesis. Biomacromolecules 2007; 8: 42-9.
86. Leslie-Barbick JE, Moon JJ, West JL. Covalently-immobilized vascular endothelial growth factor promotes endothelial cell tubulogenesis in poly(ethylene glycol) diacrylate hydrogels. J Biomater Sci Polym Ed 2009; 20: 1763-79.
87. Saik JE, Gould DJ, Keswani AK, Dickinson ME, West JL. Biomimetic hydrogels with immobilized ephrinA1 for therapeutic angiogenesis. Biomacromolecules 2011; 12: 2715-22.
88. Chen X, Aledia AS, Ghajar CM, et al. Prevascularization of a fibrin-based tissue construct accelerates the formation of functional anastomosis with host vasculature. Tissue Eng Part A 2008; 15: 1363-71.
89. Nor JE, Peters MC, Christensen JB, et al. Engineering and characterization of functional human microvessels in immunodeficient mice. Lab Invest 2001; 81: 453-63.
90. Unger RE, Sartoris A, Peters K, et al. Tissue-like self-assembly in cocultures of endothelial cells and osteoblasts and the formation of microcapillary-like structures on three-dimensional porous biomaterials. Biomaterials 2007; 28: 3965-76.
91. Unger RE, Ghanaati S, Orth C, et al. The rapid anastomosis between prevascularized networks on silk fibroin scaffolds generated in vitro with cocultures of human microvascular endothelial and osteoblast cells and the host vasculature. Biomaterials; 31: 6959-67.
92. Tremblay PL, Hudon V, Berthod F, Germain L, Auger FA. Inosculation of tissue-engineered capillaries with the host's vasculature in a reconstructed skin transplanted on mice. Am J Transplant 2005; 5: 1002-10.
93. Au P, Tam J, Fukumura D, Jain RK. Small blood vessel engineering. Methods Mol Med 2007; 140: 183-95.
94. Hirschi KK, Rohovsky SA, D'Amore PA. PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol 1998; 141: 805-14.
95. Koga M, Sudo R, Abe Y, et al. Contribution of rat endothelial progenitor cells on three-dimensional network formation in vitro. Tissue Eng Part A 2009; 15: 2729-39.
96. Yamashita J, Itoh H, Hirashima M, et al. Flk1-positive cells derived from embryonic stem cells serve as vascular progenitors. Nature 2000; 408: 92-6.
97. Cho SW, Moon SH, Lee SH, et al. Improvement of postnatal neovascularization by human embryonic stem cell derived endothelial-like cell transplantation in a mouse model of hindlimb ischemia. Circulation 2007; 116: 2409-19.
98. Levenberg S, Golub JS, Amit M, Itskovitz-Eldor J, Langer R. Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2002; 99: 4391-6.
99. Wang ZZ, Au P, Chen T, et al. Endothelial cells derived from human embryonic stem cells form durable blood vessels in vivo. Nat Biotechnol 2007; 25: 317-8.
100. Chen X, Aledia AS, Popson SA, Him L, Hughes CC, George SC. Rapid anastomosis of endothelial progenitor cell-derived vessels with host vasculature is promoted by a high density of cotransplanted fibroblasts. Tissue Eng Part A 2010; 16: 585-94.
101. Moioli EK, Clark PA, Chen M, et al. Synergistic actions of hematopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS One 2008; 3: e3922.
102. Peters MC, Polverini PJ, Mooney DJ. Engineering vascular networks in porous polymer matrices. J Biomed Mater Res 2002; 60: 668-78.
103. Hudon V, Berthod F, Black AF, Damour O, Germain L, Auger FA. A tissue-engineered endothelialized dermis to study the modulation of angiogenic and angiostatic molecules on capillary-like tube formation in vitro. Br J Dermatol 2003; 148: 1094-104.
104. Frerich B, Lindemann N, Kurtz-Hoffmann J, Oertel K. In vitro model of a vascular stroma for the engineering of vascularized tissues. Int J Oral Maxillofac Surg 2001; 30: 414-20.
105. Ikeda Y, Fukuda N, Wada M, et al. Development of angiogenic cell and gene therapy by transplantation of umbilical cord blood with vascular endothelial growth factor gene. Hypertens Res 2004; 27: 119-28.
106. De Coppi P, Delo D, Farrugia L, et al. Angiogenic gene-modified muscle cells for enhancement of tissue formation. Tissue Eng 2005; 11: 1034-44.
107. Rinsch C, Quinodoz P, Pittet B, et al. Delivery of FGF-2 but not VEGF by encapsulated genetically engineered myoblasts improves survival and vascularization in a model of acute skin flap ischemia. Gene Ther 2001; 8: 523-33.
108. Sanders JE, Wang YN, Malcolm SG, Lamont SE. Biomaterial mesh seeded with vascular remnants from a quail embryo has a significant and fast vascular templating effect on host implant tissue. Tissue Eng 2003; 9: 1271-9.
109. Stosich MS, Bastian B, Marion NW, Clark PA, Reilly G, Mao JJ. Vascularized adipose tissue grafts from human mesenchymal stem cells with bioactive cues and microchannel conduits. Tissue Eng 2007; 13: 2881-90.
110. Tsuda Y, Shimizu T, Yamato M, et al. Cellular control of tissue architectures using a three-dimensional tissue fabrication technique. Biomaterials 2007; 28: 4939-46.